WallStSmart

Cognex Corporation (CGNX)vsMKS Instruments Inc (MKSI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MKS Instruments Inc generates 289% more annual revenue ($4.07B vs $1.05B). CGNX leads profitability with a 13.6% profit margin vs 8.0%. MKSI appears more attractively valued with a PEG of 1.32. MKSI earns a higher WallStSmart Score of 61/100 (C+).

CGNX

Buy

58

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 4.7Quality: 9.0
Piotroski: 5/9Altman Z: 3.05

MKSI

Buy

61

out of 100

Grade: C+

Growth: 7.3Profit: 6.5Value: 3.3Quality: 5.0
Piotroski: 4/9Altman Z: 1.24
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CGNXUndervalued (+48.5%)

Margin of Safety

+48.5%

Fair Value

$83.47

Current Price

$60.82

$22.65 discount

UndervaluedFair: $83.47Overvalued
MKSISignificantly Overvalued (-75.4%)

Margin of Safety

-75.4%

Fair Value

$147.68

Current Price

$301.65

$153.97 premium

UndervaluedFair: $147.68Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CGNX5 strengths · Avg: 9.2/10
EPS GrowthGrowth
122.3%10/10

Earnings expanding 122.3% YoY

Debt/EquityHealth
0.0510/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.0510/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
22.3%8/10

Strong operational efficiency at 22.3%

Revenue GrowthGrowth
24.3%8/10

Revenue surging 24.3% year-over-year

MKSI2 strengths · Avg: 9.0/10
EPS GrowthGrowth
53.2%10/10

Earnings expanding 53.2% YoY

Revenue GrowthGrowth
15.2%8/10

15.2% revenue growth

Areas to Watch

CGNX2 concerns · Avg: 2.0/10
PEG RatioValuation
2.712/10

Expensive relative to growth rate

P/E RatioValuation
74.8x2/10

Premium valuation, high expectations priced in

MKSI2 concerns · Avg: 2.0/10
P/E RatioValuation
74.6x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.242/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CGNX

The strongest argument for CGNX centers on EPS Growth, Debt/Equity, Altman Z-Score. Revenue growth of 24.3% demonstrates continued momentum.

Bull Case : MKSI

The strongest argument for MKSI centers on EPS Growth, Revenue Growth. Revenue growth of 15.2% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bear Case : CGNX

The primary concerns for CGNX are PEG Ratio, P/E Ratio. A P/E of 74.8x leaves little room for execution misses.

Bear Case : MKSI

The primary concerns for MKSI are P/E Ratio, Altman Z-Score. A P/E of 74.6x leaves little room for execution misses.

Key Dynamics to Monitor

MKSI carries more volatility with a beta of 2.00 — expect wider price swings.

CGNX is growing revenue faster at 24.3% — sustainability is the question.

CGNX generates stronger free cash flow (42M), providing more financial flexibility.

Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MKSI scores higher overall (61/100 vs 58/100) and 15.2% revenue growth. CGNX offers better value entry with a 48.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cognex Corporation

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Cognex Corporation offers machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks globally. The company is headquartered in Natick, Massachusetts.

Visit Website →

MKS Instruments Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.

Visit Website →

Want to dig deeper into these stocks?